Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00645242 · ClinicalTrials.gov registry record · Phase 3
A Study Of Diflucan In Children With Ringworm Of The Scalp
A Phase 3 study of Tinea Capitis, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 185
- Enrollment target
- 20
- Study locations
NCT00645242: Completed Phase 3 study of Tinea Capitis, sponsored by Pfizer.
NCT00645242 is a Phase 3 study of Tinea Capitis that has completed, run by Pfizer. The registered enrollment target is 185 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (76% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00645242, a Phase 3 study of Tinea Capitis, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 185 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and efficacy of fluconazole for the treatment of tinea capitis in pediatric patients aged 3 to 12 years.
Conditions Studied
Interventions
- DRUG fluconazole
Study Locations (20)
Louisiana
- Pfizer Investigational Site - Gretna
- Pfizer Investigational Site - New Orleans
- Pfizer Investigational Site - Shreveport
Florida
- Pfizer Investigational Site - Miami
- Pfizer Investigational Site - Miami
Illinois
- Pfizer Investigational Site - Chicago
- Pfizer Investigational Site - Evanston
North Carolina
- Pfizer Investigational Site - Garner
- Pfizer Investigational Site - Raleigh
Ohio
- Pfizer Investigational Site - Cleveland
- Pfizer Investigational Site - Columbus
Alabama
- Pfizer Investigational Site - Montgomery
Arkansas
- Pfizer Investigational Site - Little Rock
California
- Pfizer Investigational Site - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2002-11 |
| Est. Completion | 2003-03 |
| Phase | Phase 3 |
What the finished NCT00645242 record still lists
NCT00645242 is an interventional study that assigns participants to a tested intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Tinea Capitis appearing as the primary indexed condition, and to 1 intervention - of which fluconazole is the first listed.
NCT00645242 names 20 study sites across 14 states, led by Louisiana, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT00645242 about?
NCT00645242 is a clinical study titled "A Study Of Diflucan In Children With Ringworm Of The Scalp". The purpose of this study is to evaluate the safety and efficacy of fluconazole for the treatment of tinea capitis in pediatric patients aged 3 to 12 years.
What is the current status of trial NCT00645242?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 185 participants. The study started on 2002-11. Estimated completion is 2003-03.
What conditions does trial NCT00645242 study?
This clinical trial studies the following conditions: Tinea Capitis.
What interventions are being tested in trial NCT00645242?
The interventions under investigation include: fluconazole (DRUG).
Who is sponsoring clinical trial NCT00645242?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00645242 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00645242's enrollment target sits among peer trials
185 1417th of 2000 higher than 583 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia